Types segmentation categorizes scoliosis based on etiological origin, which directly shapes treatment pathways and market demand. Idiopathic scoliosis, accounting for roughly 70 % of cases, is further divided into adolescent‑onset and adult‑onset sub‑categories; adolescent cases dominate brace sales, while adult cases drive surgical device utilization, contributing the largest share of revenue. Congenital scoliosis, representing about 10 % of the patient pool, requires early surgical correction due to vertebral malformations, thereby influencing the demand for specialized implants and intra‑operative imaging. Neuromuscular scoliosis, comprising approximately 15 % of the market, is associated with conditions such as cerebral palsy and muscular dystrophy; its management relies heavily on customized bracing systems and complex fusion procedures, reflecting higher per‑patient cost. Degenerative scoliosis, though only 5 % of prevalence, primarily affects the elderly and stimulates growth in minimally invasive correction technologies. Collectively, these type‑based segments define the Scoliosis Management segmentation framework, allowing analysts to allocate resources according to disease prevalence, age distribution, and procedural complexity.
